Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Athul Sanjeev, PhD
Advisor, RNA Technology and Process Development at Eli Lilly & Company
Speaker

Profile

Athul is an Advisor in mRNA Process Development at Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, where he focuses on advancing RNA-based therapeutics. He holds a Ph.D. in Chemistry from Northeastern University and brings extensive expertise in RNA and protein engineering and process development. His work spans the intersection of molecular science and bioprocess innovation, contributing to the growing field of mRNA medicines.

Agenda Sessions

  • Engineering T7 RNA Polymerase to Reduce Double Stranded RNA Impurities and Improve Capping Efficiency

    , 11:45am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Athul at TIDES USA: Oligonucleotide & Peptide Therapeutics